MedPath

Comparison of two regimens of fluconazol in treatment of cutaneous lieshmaniasis

Phase 2
Conditions
Cutaneous leishmaniasis
Cutaneous leishmaniasis.
Registration Number
IRCT138710221542N1
Lead Sponsor
Shiraz University of Medical Scienses
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
94
Inclusion Criteria

age over 12 years, positive PCR for leishmanisis and no treatment in two months ago, duration of disease is lower than 4 months.
Exclusion criteria: pregnancy, breast feeding, possibility of pregnancy in future, number of lesion over ten, history of liver disease and high BUN or Cr.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reepithelialization. Timepoint: every two week. Method of measurement: observation.;Size of lesion. Timepoint: every two week. Method of measurement: with ruler.;Induration of lesion. Timepoint: every two week. Method of measurement: physical examination.
Secondary Outcome Measures
NameTimeMethod
Rising of liver enzyme, BUN and Cr. Timepoint: every two week. Method of measurement: Blood sample and laboratory measurment.;Nausea and vomitting. Timepoint: every two week. Method of measurement: History.
© Copyright 2025. All Rights Reserved by MedPath